41. Artificial Heart Program At the University of Pittsburgh. Comprised of a basic science and engineering program for developmental research and an applied clinical program aimed at treating endstage heart failure. http://www.upmc.edu/ArtificialHeart/

42. Heart Failure - MayoClinic.com heart failure means your heart can t efficiently pump blood throughout your body.Medications, and sometimes surgery, help you manage this condition. http://www.mayoclinic.com/invoke.cfm?id=DS00061

43. Honeywell HomMed, LLC | Welcome To Honeywell HomMed. The Future Of Health Care I Offering daily athome health monitoring products for people with congestive heart failure, COPD, and diabetes. http://www.hommed.com

Site Map Contact Us HONEYWELL ACQUIRES HomMed HomMed ... Unit Shipments Jump 51% in First Half 2004 Welcome to Honeywell HomMed The Future of Health Care in America® Text Size The mission of Honeywell HomMed is, “To improve the quality of life of patients and dramatically reduce the cost of healthcare.” We now collect more data on our automobile engines than we do for most people in their lifetimes, except when they’re hospitalized, which is really too late. The Honeywell HomMed Telemonitoring System has been designed for all individuals, regardless of their overall health. Thank you for visiting our web site. We’ve designed it to allow you to easily navigate within the site and within each section. The menu at the top of this page allows you to quickly locate your audience profile and learn how Honeywell HomMed can meet your needs. The menu bar on the right-hand side includes specifics relating to the company, its products and how our products impact healthcare. It’s all backed up by clinical and financial data as well as independent analysis on the effectiveness of telemonitoring. But more importantly learn from some of the many people we’ve helped about how Honeywell HomMed has positively changed their lives and the lives of family members. Plus you can view how simple and easy to use Honeywell HomMed’s System truly is in the video demo. Please take the time to explore our site and see how Honeywell HomMed can benefit you, a co-worker or a loved one.

44. Heart Failure heart failure is a disorder in which the heart loses its ability to pump bloodefficiently throughout the body. The oxygen and nutrients in the blood http://www.netdoctor.co.uk/diseases/facts/heartfailure.htm

Search: All NetDoctor Diseases Medicines NetDoctor.co.uk Home News and features News News archive Newsletter Features Encyclopaedia Diseases Examinations Medicines Premium services SMS services StayQuit thediet Health centres ADHD Allergy and asthma Children's health Depression ... All health centres Discussion and support Discussion forums Support groups Services Ask the doctor Find a hospital Search Medline Test yourself Information About NetDoctor Commercial opportunities NetDoctor.com Heart failure Reviewed by Dr Neal Uren , consultant cardiologist, Dr Reginal Odbert , GP and Dr Patrick Davey , cardiologist What is heart failure? Heart failure is a disorder in which the heart loses its ability to pump blood efficiently throughout the body. The oxygen and nutrients in the blood provide the body with the energy it needs to operate efficiently. Heart failure may affect the left, right, or both sides of the heart. If the left half of the heart fails (left ventricular failure), fluid will build up in the lungs due to congestion of the veins of the lungs. If the right half of the heart fails (right ventricular failure), general body vein pressure will increase and fluid will accumulate in the body, especially the tissues of the legs and abdominal organs (of these, the liver is the organ most likely to be affected).

45. Biogen Inc. Established manufacturer of drug for treatment of multiple sclerosis, with research focusing on respiratory diseases and congestive heart failure. Offices throughout Europe, Canada with headquarters in Cambridge, Massachusetts. http://www.biogen.com/

location.replace("site/home.html");

46. Congestive Heart Failure Canadian site looking at prevention and treatment as well as evaluation of thisdisease. http://www.santepub-mtl.qc.ca/mdprevention/fiches/coeur/heart.html

Congestive heart failure The most frequent causes of relapse are improper observance of treatment, poorly controlled hypertension, other heart problems, and infections. How can we talk about prevention? Simply by examining the causes, i.e. ischaemic heart disease, high blood pressure, cardiomyopathies, diabetes, and valvulopathies. Since the first two conditions are the most frequently associated, we believe that there is a link between strategies for preventing ischaemic heart disease and the prevention of heart failure. Heart Failure Continuum of Heart Failure Prevention Evaluation of Heart Failure Treatment of heart failure according to the type of ventricular dysfunction Resources No resources for patient Comments and suggestions: Dr Jean Cloutier Collaboration Association des Médecins Omnipraticiens de Montréal Information is updated regularly Update : July 7, 1999 Haut

47. Quinapril.com | All You Need To Know About Quinapril The official site for the brand name drug, Accupril. Offers detailed information for this medication which is used to treat high blood pressure and heart failure. http://www.quinapril.com/

Quinapril .com all you need to know about quinapril home product info forums tell a friend mailing list ... advertise (kwin' a pril) Brand name(s): Accupril About Quinapril.com Quinapril.com is the official web site dedicated to quinapril, brand name(s) Accupril. This site is unique in that it provides you with real experiences from people who are using or who have used quinapril. Quinapril.com is the perfect place to help you find resources and information related to quinapril. It is a meeting point for visitors who are perhaps looking for suppliers, manufacturers of this product and who are interested in contacting people who have had experience with quinapril. Why is this medication prescribed? Quinapril is used to treat high blood pressure and heart failure. It decreases certain chemicals that tighten the blood vessels so that blood flows more smoothly and the heart can pump more efficiently. This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information. See more product info here Visit our Quinapril forums forums are a valuable community meeting place for members who wish to give and receive support and information on Quinapril.

48. The Physician And Sportsmedicine: Congestive Heart Failure Resource for those who are active or wish to begin being active. Discusses causes of exercise intolerance, exercise benefits, an exercise prescription as well as what to look out for. http://www.physsportsmed.com/issues/1998/08aug/clark.htm

Congestive Heart Failure: Training for a Better Life James R. Clark, MD, with Carl Sherman Series Editor: Nicholas A. DiNubile, MD THE PHYSICIAN AND SPORTSMEDICINE - VOL 26 - NO. 8 - AUGUST 98 In Brief: Congestive heart failure (CHF) patients who exercise regularly can increase exercise tolerance, decrease dyspnea and fatigue, reduce the risk of arrhythmias, and improve quality of life. Initial stress testing is important for assessing a patient's physiologic response to exercise and for establishing a target heart rate for an individualized exercise program. Patients may need to begin aerobic exercise with interval training and progress slowly. Strength exercise is also useful. Exercise used along with the customarily prescribed CHF medications improves symptoms more than either modality alone. T he incidence of congestive heart failure (CHF) and the resulting death rate (1) have risen significantly in recent decades, partially because of the aging of the population. Over 4 million Americans now suffer from the disorder, which, broadly defined, is an inability of the heart to pump enough blood to meet the body's metabolic needs. The causes are many, but the vast majority of cases involve left ventricular dysfunction related to coronary artery disease, hypertension, or idiopathic dilated cardiomyopathy (2). CHF patients were traditionally counseled to rest and avoid exercise in order to delay disease progression and to promote diuresis induced by bed rest (3). However, CHF theory and clinical practice have changed radically, especially in the last decade, as research has demonstrated that exercise offers much gain at little risk (3-9). Indeed, most CHF patients who exercise can markedly improve their functional status and quality of life (3,5-8). In addition, exercise may reduce the risk of death for CHF patients, just as it does for patients who have coronary artery disease (10).

49. Essentials Of The Diagnosis Of Heart Failure - March 1, 2000 - American Academy The first step in diagnosing heart failure is to obtain a complete clinical history . Diagnosing heart failure in elderly patients may be particularly http://www.aafp.org/afp/20000301/1319.html

Advanced Search AAFP Home Page Journals Vol. 61/No. 5 (March 1, 2000) Essentials of the Diagnosis of Heart Failure FADI SHAMSHAM, M.D., and JUDITH MITCHELL, M.D. State University of New York Health Science Center at Brooklyn, Brooklyn, New York H eart failure affects an estimated 4.9 million Americans, or 1 percent of adults 50 to 60 years of age and 10 percent of adults in their 80s. Each year, about 400,000 new cases of heart failure are diagnosed in the United States. This clinical syndrome is the most frequent cause of hospitalizations in the elderly and is responsible for 5 to 10 percent of all hospital admissions. Heart failure causes or contributes to approximately 250,000 deaths every year. The clinical syndrome of heart failure manifests when cellular respiration becomes impaired because the heart cannot pump enough blood to support the metabolic demands of the body, or when normal cellular respiration can only be maintained with an elevated left ventricular filling pressure. TABLE 1 Boston Criteria for Diagnosing Heart Failure Criterion Point value* Category I: history Rest dyspnea Orthopnea Paroxysmal nocturnal dyspnea Dyspnea while walking on level area Dyspnea while climbing Category II: physical examination Heart rate abnormality (1 point if 91 to 110 beats per minute; 2 points if more than 110 beats per minute)

50. Cardiomedics -- Company History; Angina Pain:Angina Treatment, Angioplasty Alter Offers information on external counterpulsation for treatment of angina, chest pain, coronary artery disease and heart failure. http://www.cardiomedics.com

51. Congestive Heart Failure (CHF) - CardiologyChannel Information on diagnosis and treatment of congestive heart failure monitored byboard certified Cardiologists. http://www.cardiologychannel.com/chf/

Home Search SiteMap Ask the Dr. ... Medical Store CONGESTIVE HEART FAILURE Overview Causes Symptoms Diagnosis ... Videos CONDITIONS Angina Aortic Stenosis Atrial Fibrillation Chest Pain ... Congestive Heart Failure Endocarditis Heart Attack High Cholesterol Hypertension ... Stroke DIAGNOSTIC TESTS Blood Pressure Cardiac Catheterization Electrocardiogram Imaging Tests Physical Exam Stress Tests TREATMENTS Coronary Angioplasty Pacemaker RESOURCES Anatomy Cardiology Forum Clinical Trials Glossary ... What Is a Cardiologist? FOR DOCTORS ONLY Website Services Get Listed in MDLocator CME ABOUT US Healthcommunities.com Testimonials Overview Congestive heart failure, or heart failure, is a condition in which the heart is unable to adequately pump blood throughout the body and/or unable to prevent blood from "backing up" into the lungs. In most cases, heart failure is a process that occurs over time, when an underlying condition damages the heart or makes it work too hard, weakening the organ. Heart failure is characterized by shortness of breath (dyspnea) and abnormal fluid retention, which usually results in swelling (edema) in the feet and legs. Normal Blood Flow of the Heart The heart consists of four chambers: the right atrium , the left atrium , the right ventricle , and the left ventricle , and four major valves: the mitral valve , the tricuspid valve , the aortic valve , and the pulmonary valve . Atria are relatively thin-walled chambers that receive blood from the circulatory system and from the lungs. Ventricles are muscular chambers that pump blood into the circulatory system and into the lungs.

52. Coreg, Treatment For Hypertension, Recent Heart Attack And Heart Failure Includes information for patients and families about heart failure diagnosis, treatment, healthy food choices, lifestyle and prescribing information. http://coreg.com

It is important to take your medicine every day as directed by your doctor or healthcare provider. Do not stop taking Coreg suddenly, because you could have serious side effects, such as chest pain or a heart attack. If your doctor decides you should stop taking Coreg , your doctor or healthcare provider may slowly reduce your dose over a period of time before stopping it completely. Some common side effects associated with Coreg include shortness of breath, a slow heartbeat, weight gain, fatigue, dizziness or faintness. People taking Coreg who have any of these symptoms should call their doctor. Additionally, if patients experience fatigue or dizziness, they should sit or lie down and avoid driving or hazardous tasks. As with any medicine, there are some people who should not take Coreg . The people who should not take Coreg include those with severe heart failure who are hospitalized in the intensive care unit. Also, people who require certain intravenous medications that help support their circulation (inotropic medications) should not receive

53. Acorn Cardiovascular | Reshaping Heart Failure The firm was incorporated in late 1996 and has aggressively developed the Cardiac Support Device (CSD), an investigational device designed to assist in the treatment of NYHA Class III heart failure. http://www.acorncv.com/

Home Media Relations Careers Contact Us Acorn Cardiovascular is a medical device company pursuing innovative and effective treatments for patients with heart failure. Based on a strong scientific foundation, we develop novel therapies to successfully treat heart failure and restore hope for a better, longer life. For Healthcare Providers June 22, 2005 - Advisory Panel Does Not Recommend Approval for New Heart Failure Therapy. Researchers and Company Representatives Remain Optimistic. Full Story (PDF) November 8, 2004 - Acorn Cardiovascular Announces Positive Clinical Trial Results at American Heart Association Scientific Sessions. Full Story (PDF) Information regarding heart failure and cardiac support device therapy will be presented at upcoming medical symposia. For a schedule of events, click here

54. ACC/AHA Guidelines For The Evaluation And Management Of Heart Failure - Table Of HUNT ET AL., EVALUATION AND MANAGEMENT OF heart failure Endorsed by the HeartFailure Society of America. Committee Members Sharon A. Hunt, MD, FACC, http://www.acc.org/clinical/guidelines/failure/hf_index.htm

var showMenu="ExpandMain:clinical;"; // document.modified = "Monday August 15, 2005"; document.modified = "08/15/2005"; You have accessed an outdated version of this guideline. You will be redirected immediately to the correct version. If you have not been redirected, click here

55. Redirection To Sanofi-Synthelabo US Website A phosphodiesterase inhibitor (PDE III) that is indicated for the shortterm intravenous treatment of patients with acute decompensated heart failure. Site provides information for health care professionals and patients. http://www.primacor.com/

56. THE MERCK MANUAL--SECOND HOME EDITION, Ch. 25, Heart Failure heart failure due to systolic dysfunction usually develops because the heart heart failure has two main forms systolic dysfunction (which is more http://www.merck.com/mmhe/sec03/ch025/ch025a.html

var externalLinkWarning = "The link you have selected will take you to a site outside Merck and The Merck Manuals.*n*nThe Merck Manuals do not review or control the content of any non-Merck site. The Merck Manuals do not endorse and are not responsible for the accuracy, content, practices, or standards of any non-Merck sources."; Search The Second Home Edition , Online Version Search Index A B C D ... Z Sections Accidents and Injuries Blood Disorders Bone, Joint, and Muscle Disorders Brain, Spinal Cord, and Nerve Disorders ... Women's Health Issues Resources Anatomical Drawings Multimedia Pronunciations Weights and Measures ... , Online Version Section Heart and Blood Vessel Disorders Chapter Heart Failure Topics Heart Failure Heart Failure Buy The Book Print This Topic Email This Topic Pronunciations adrenaline aldosterone amyloidosis angina ... warfarin Heart failure is a disorder in which the heart pumps blood inadequately, leading to reduced blood flow, back-up (congestion) of blood in the veins and lungs, and other changes that may further weaken the heart. Heart failure can occur in people of any age, even in young children (especially those born with a heart defect). However, it is much more common among older people, because older people are more likely to have disorders that damage the heart muscle and because age-related changes in the heart tend to make the heart pump less efficiently. Heart failure develops in about 1 of 100 people. The disorder is likely to become more common because people are living longer and because, in some countries, certain risk factors for heart disease (such as smoking, high blood pressure, and a high-fat diet) are affecting more people.

57. CHFpatients.com - Ace Inhibitors For Heart Failure Explained Information for patients about the primary drug treatment for heart failure. http://www.chfpatients.com/ace.htm

Heartbytes New CHF Drugs IV Drugs Surgeries Archived articles here Updated May 22, 2005 Ace Inhibitors benazepril - Lotensin by Novartis captopril - Capoten by Bristol-Myers Squibb enalapril - Vasotec by Merck fosinopril - Monopril by Bristol-Myers Squibb imidapril - Not approved for human use in the USA - approved in Japan lisinopril - Prinivil by Merck or Zestril by Astra-Zeneca moexipril - Univasc by Schwarz Pharma quinapril - Accupril by Pfizer perindopril erbumine - Aceon by Rhone-Polenc Rorer ramipril - Altace by Hoechst Marion Roussel, King Pharmaceuticals trandolapril - Mavik by Knoll Pharmaceutical (BASF) ARBS - Angiotension II Receptor Blockers candesartan cilexetil - Atacand by Astra Merck eprosartan - Teveten irbesartan - Avapro by Sanofi losartan - Cozaar by Merck olmesartan medoxomil - Benicar by Sankyo Pharma telmisartan - Micardis valsartan - Diovan by Novartis Angiotensin II - The Problem We are talking about the chemical messengers in the body called neurohormones . For those of us with heart failure, the neurohormone called angiotensin II is not a good thing. Angiotensin II helps controls the cardiovascular system. It causes blood vessels to shrink (vasoconstriction), which raises blood pressure. Angiotensin II also causes the body to release aldosterone - a substance that causes our kidneys to retain sodium and fluid, causing

58. THE MERCK MANUAL, Sec. 16, Ch. 203, Heart Failure No definition of heart failure (HF) is entirely satisfactory. Congestive heartfailure (CHF) develops when plasma volume increases and fluid accumulates in http://www.merck.com/mrkshared/mmanual/section16/chapter203/203a.jsp

59. Elsevier.com - European Journal Of Heart Failure The European Journal of heart failure is the International Journal of the EuropeanSociety of Cardiology dedicated to the advancement of knowledge in the http://www.elsevier.com/wps/product/cws_home/601480

Home Site map Regional Sites Advanced Product Search ... European Journal of Heart Failure Journal information Product description Editorial board Audience Abstracting/indexing ... For advertising and sponsorships For Authors Guide for authors Online Submission Subscription information Bibliographic and ordering information Conditions of sale Dispatch dates Journal related information Impact factor Most downloaded articles Other journals in same subject area About Elsevier ... Select your view EUROPEAN JOURNAL OF HEART FAILURE Journal of the Heart Failure Association of the European Society of Cardiology Editor-in-Chief: Karl Swedberg See editorial board for all editors information Description The European Journal of Heart Failure is the International Journal of the European Society of Cardiology dedicated to the advancement of knowledge in the field of heart failure. The Journal publishes reviews and editorials in order to improve the understanding, prevention, investigation and treatment of heart failure. Molecular and cellular biology, pathology, physiology, electrophysiology, pharmacology, as well as the clinical, social and population sciences all form part of the discipline that is heart failure. Accordingly, submission of manuscripts on basic, clinical and population sciences is invited. Original contributions on nursing, care of the elderly, primary care, health economics and other specialist fields related to heart failure are also welcome. ISSN: 1388-9842 Imprint: ELSEVIER Commenced publication 1999 Subscription for the year 2006, Volume 8, 6 issues

60. BioMed Central | Current Heart Failure Reports Current heart failure Reports, Volume 2, Issue 2 (June 2005) more info.Access to the full text or PDF of articles from Current heart failure Reports http://www.biomedcentral.com/currheartfailrep/

home journals A-Z subject areas advanced search ... my BioMed Central Quick Search Current Heart Failure Reports BioMed Central PubMed Central PubMed Jump to article Current Heart Failure Reports Home Journal site Advanced search Archive About this journal ... Most viewed Current Heart Failure Reports, Volume 2, Issue 3 (September 2005) more info Access to the full text or PDF of articles from Current Heart Failure Reports requires a subscription to the journal. Abstracts are freely accessible. previous issue Web Alert Web Alert Flora Sam MD Heart Failure Reports September Abstract Full text PDF Reports Mechanisms of Ventricular Arrhythmias in Heart Failure Matthew W Ebinger DO, Subramaniam D Krishnan MD, Claudio D Schuger MD Heart Failure Reports September Abstract Full text PDF PubMed ... Sudden Death in Nondilated Cardiomyopathies: Pathophysiology and Prevention Anand Soni MD, Paul LeLorier MD Heart Failure Reports September Abstract Full text PDF PubMed ... Sudden Cardiac Death and the Role of Device Therapy in Dilated Cardiomyopathy Prash M Jayaraj MD, Kevin M Monahan MD Heart Failure Reports September Abstract Full text PDF PubMed ... Role of Vasopressin Antagonists in the Management of Acute Decompensated Heart Failure Cesare A Orlandi MD, Christopher A Zimmer MD MBA, Mihai Gheorghiade MD

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

Page 3     41-60 of 186    Back | 1  | 2  | 3  | 4  | 5  | 6  | 7  | 8  | 9  | 10  | Next 20